The unique physicochemical properties of ENMs are being exploited for use in a growing variety of commercial nano-enabled products (NEPs), including electronics, cosmetics, and structural materials, as well as a wide variety of products for antimicrobial, agricultural, medical, therapeutic, and diagnostic applications [1] [2] [3] [4] [5] [6] [7] [8] . The rapid proliferation and commercialization of these ENMs and associated NEPs poses a potential risk of both occupational and consumer exposures to materials for which toxicological data are extremely limited [9] [10] [11] [12] [13] [14] [15] [16] [17] . Moreover, the high degree of variability in physicochemical properties such as composition, size, morphology, surface topology, chemistry and modifications, crystallinity, and impurity content among these ENMs presents a substantial challenge to the nanotoxicology field [18] [19] [20] [21] [22] . In addition, human exposure is not limited to pristine ENMs but also includes a wide variety of particles released from NEPs across their life cycle, including at the consumer use and disposal stages 6, 23, 24 . Indeed, the potential for exposure from such life cycle particulate matter (LCPM) may exceed that of pristine ENMs 23 . To complicate the matter further, the physicochemical properties and toxicological profiles of LCPM may differ greatly from those of the corresponding pristine ENMs 14, [25] [26] [27] [28] [29] [30] [31] .
forms having diameters on the same order as the primary particles, to formation of large micron-sized agglomerates containing hundreds or thousands of primary particles. Because the sedimentation rate of a particle in suspension is proportional to the square of its diameter, a tenfold difference in size results in a 100-fold difference in sedimentation rate, and roughly the same fold difference in delivered in vitro dose 37 . The other key determinant of transport is effective density. Because agglomerates can contain relatively large amounts of medium, the effective density of suspended ENMs can be much less than the density of the primary particle material, and it is often closer to the density of the medium 36 . Because the sedimentation rate is directly proportional to the difference between the medium and the agglomerate effective density, this can also have a large effect on the dose delivered to cells over time. It was recently demonstrated that buoyant ENMs present a special case and challenge for characterization and dosimetric analysis 46 . If the raw material density is lower than the medium density, as in the case of some conjugated polymers, nanobubbles and liposomes used in nanomedicine and food applications [47] [48] [49] [50] , the agglomerates do not settle, but instead rise or float away from cells over time, making the dose-response relationship impossible to determine. We have recently demonstrated that, in a standard cell culture system, buoyant polypropylene ENMs have no effect on cells, whereas in an inverted cell culture system, in which cells are oriented above the ENM suspension, the same ENMs produced dose-dependent increases in cytotoxicity and reactive oxygen species generation 46 .
Dosimetry can affect interpretation of in vitro hazard ranking results. In vitro nanotoxicology is comparative in nature, often relying on previously studied nanomaterials as controls to provide hazard rankings among large panels of ENMs. However, studies often fail to sufficiently characterize colloidal properties of suspended materials or to account for effects of these properties on fate and transport and the exposure dose delivered to cells. The critical role of dosimetry in interpretation of in vitro nanotoxicology studies was highlighted in the seminal work of Wittmaack, who reported the formation and rapid settling and accumulation of micron-sized agglomerates of suspended nanostructured powders 51 . Importantly, Wittmaack pointed out that the resulting exceedingly high exposure doses could cause physical overload effects from overlying or internalized ENMs that could be misinterpreted as toxicity. Additional studies by Wittmaack reported that in vitro toxicity of SiO 2 nanoparticles was dependent upon the areal density of nanoparticle mass delivered to cells over the exposure duration, further emphasizing the importance of particle kinetics in interpretation of biological responses 52 . Thus, an ENM that forms large and dense-and thus rapidly sedimenting-agglomerates that quickly concentrate around cells may be reported as more toxic than one that forms smaller and less dense-and thus slower-settling-agglomerates, even though the latter material might well be more toxic than the former at equivalent delivered doses 53 . Recent studies report the impact of agglomerate properties on the time required for ENM delivery to cells in vitro 37, 54 , and demonstrate the subsequent impacts of dosimetry on hazard ranking of large panels of low-aspect-ratio ENMs 53 .
Moreover, cell uptake and translocation in vitro is strongly dependent on ENM characteristics and composition, protein content of the medium, and the dose delivered to cells 55, 56 .
Thus, methods for reproducibly generating ENM suspensions, and accurate ENM-and media-specific characterization and dosimetry in vitro, are essential for predicting uptake and translocation biokinetics and biological effects in vitro. More importantly, doses used for in vitro testing should be matched with in vivo exposure doses, which in turn should be based on realistic potential human exposures 34, 35, 39 . Until recently, this was rarely done, in part because the tools necessary to correctly match in vivo and in vitro exposures have not been available. However, with accurate in vitro and in vivo computational dosimetry modeling now available, it is possible to bring in vitro cellular and in vivo animal exposures into alignment. For example, delivered doses for in vivo particle inhalation exposures can be quantified using the multiple-path particle dosimetry model (MPPD) 57 . The MPPD provides, for a given human or animal model (lung/ airway anatomy and geometry, breathing parameters), ENM aerosol characteristics, and exposure time, an estimate of the ENM mass deposited per unit area of the lung, and is the gold standard for dosimetry in animal studies of ENM inhalation exposures 34, 58, 59 . The in vivo-deposited mass per unit lung area obtained from a MPPD can then be used as a target deposited mass per area for in vitro experiments, and the corresponding initial administered in vitro ENM concentrations needed to obtain that target delivered dose can be determined using computational modeling approaches such as the volumetric centrifugation method-in vitro sedimentation, diffusion and dosimetry (VCM-ISDD) or distorted grid (DG) model 14, 37, 54, 60 .
Thus, in addition to errors in hazard ranking, the failure to adequately account for fate and transport probably contributes to the inconsistent results within and especially between laboratories, to skewed relationships between toxicological outcomes and physicochemical properties, and to conflicting findings between in vitro and in vivo experiments. For these reasons, development of an integrated, validated dosimetry methodology has become a high priority in in vitro nanotoxicology.
Recently, integrated, hybrid in vitro dosimetric platforms have been developed to address this important issue. Such integrated platforms include the preparation and proper characterization of ENM suspensions and the use of advanced numerical fate and transport methods to estimate the delivered dose metrics 37, 54 . Here we provide a detailed protocol for such a methodology, which if adopted could ensure consistent test ENM suspensions for in vitro toxicological testing across laboratories and accurate calculation of dose metrics as a function of exposure time in an in vitro culture system.
Development of the protocol based on the integrated in vitro dosimetry methodology
We present here a multistep in vitro dosimetric protocol that enables nanotoxicologists to quantify delivered dose metrics as a function of time 54 . This protocol consists of three interconnected parts: (i) ENM dispersion preparation; (ii) ENM dispersion characterization; and (iii) numerical fate and transport modeling to derive delivered dose metrics (Fig. 1) . We explain these in more detail below. sonication energy (DSE) and duration in units of J/ml, and (ii) determination of the material-specific critical delivered sonication energy (DSE cr ) required to achieve a suspension with the smallest possible agglomerates that are minimally polydisperse and maximally stable over time. Importantly, sonication must be performed in water rather than in culture media in order to avoid generation of reactive oxygen species by sonolysis and denaturing of proteins 33 . To generate dispersions in media for use in experiments, the material is first sonicated in deionized water with a delivered sonication energy (J/ml) equal to DSE cr , and subsequently diluted in cell culture media to the desired initial concentration for application to cells (Fig. 2) . Part 2: ENM dispersion characterization. Characterization has become an increasing concern in ENM toxicological testing 33, [61] [62] [63] [64] [65] [66] . Robust characterization, including physical, chemical, and morphological properties of ENM powders, as well as colloidal properties of suspended ENMs, is essential for understanding biointeractions with cells. Lack of suitable ENM characterization, either of the pristine nanomaterials or of the dispersions, can call into question the validity and interpretability of in vitro toxicity data. Recent work by Warheit and Donner and others emphasizes the necessity of establishing and adopting standardized experimental procedures in order to make reliable toxicological determinations 53, 67, 68 . A summary of pristine ENM properties commonly evaluated is presented in Table 1 . Here we will focus on the colloidal properties of ENM suspensions that drive particle transport in liquid suspension, and thus determine the dose delivered to cells in vitro, namely the size (diameter) and effective density of the formed agglomerates. In the protocol presented here, we describe measurement of size distribution by dynamic light scattering (DLS), and measurement of effective density using the VCM. However, as discussed in more detail below, there are a variety of other instruments and methods available for accurately measuring size and effective density that can be used in place of the specific methods presented in this protocol.
Although analytical ultracentrifugation (AUC) is the gold standard for measurement of ENM effective density, it requires relatively expensive equipment not available in many labs and is limited in terms of throughput. The VCM was developed by the authors to allow high-throughput measurement of effective density using a standard bench-top centrifuge and relatively inexpensive packed cell volume (PCV) tubes 36 . Figure 3 presents a schematic overview of effective density measurement using the VCM. A known volume of suspension of a known ENM concentration is loaded into a PCV tube and centrifuged to collect the agglomerates in the capillary section of the tube. From the measured volume of the pellet and known volume of ENM, the effective density can be calculated as a weighted average of media and ENM.
Part 3: Fate and transport modeling for calculation of dose delivered to cells. With the stable suspension created and characterized, numerical modeling can then be used to compute the delivered dose metrics as a function of exposure time. The 1D model presented here, referred to as the DG fate and transport model, provides both deposition and concentration metrics, and concentration profiles of ENMs across the well as a function of time 37 . The DG model also allows modeling of variable binding kinetics at the bottom of the well, accommodates simultaneous simulation of polydisperse suspensions, and allows modeling of dissolution for soluble or partially soluble ENMs. The program is implemented in MATLAB, and it typically runs in a few minutes before exporting dose metrics to an Excel file.
The entire integrated methodology, as well as its core components, has previously been experimentally validated, as described in below in detail, for a variety of metal and metal oxide ENMs 36, 37, 54, 55 , and is suited to most low-aspect-ratio nanomaterials.
Comparison with other methods
Several groups have recently proposed standardized dispersion protocols that result in reproducible and stable nanoparticle dispersions in media relevant for in vitro toxicity studies 33, [69] [70] [71] [72] [73] . Review of these proposed standardized protocols highlights the key elements necessary for achieving and characterizing reproducible, stable, and relatively monodisperse suspensions for in vitro toxicity testing 68 . The protocol detailed here draws on best practices identified from those protocols, and it achieves similar results in terms of agglomerate size, size distribution, and agglomerate stability over time 33 . In addition to DLS, the agglomerate size distribution can be measured using a variety of methods, including AUC, hydrodynamic chromatography, nanoparticle tracking analysis, laser diffraction spectrometry, X-ray disc centrifugation, and tunable resistive pulse sensing 38, 54, 74 . Because DLS is easy to use and available in most nanotoxicology labs, and DLS output is suitable and has been validated for computational fate and transport modeling (see discussion of validation of computational modeling based on DLS measurements of size distribution below) 36, 37, 54, 55 , our protocol uses this method of size characterization. However, any of the other available methods for size characterization may be substituted for the DLS characterization presented here. Measurement of effective density has presented a greater challenge. Despite its importance as a determinant of particle fate and transport, effective density is rarely characterized or reported for nanoparticle suspensions used in cellular toxicity studies 68 . This parameter can be empirically estimated based on a theoretical fractal-based model for agglomeration 75 , or it can be calculated from the sedimentation coefficient measured by AUC 76 . Although AUC provides accurate direct measurement of effective density, the utility of this technique is hindered by the need for expensive laboratory equipment not often found in nanotoxicology labs, and by relatively low throughput. This protocol therefore provides detailed instructions for the recently developed VCM-an inexpensive, accessible, and high-throughput method for measuring effective density. In previous publications, we have validated VCM measurements of effective density against gold-standard AUC measurements for a variety of both high-and low-density particles, as well as for the suitability of VCM measurements for validated computational modeling of particle fate and transport in vitro (see validation of computational modeling based on VCM measurements of effective density below) 36, 37, 54, 55 . Nevertheless, AUC remains a gold standard for the determination of effective density, and it can be used in place of the VCM approach presented in this protocol. The first computational model for estimating fate and transport of ENMs in vitro was the ISDD model, reported by Hinderliter et al. 77 , which made it possible to calculate the per well bottom surface area deposited mass, surface area, and number of particles, as well as the fraction of total suspended material deposited as a function of time. This provided a ground-breaking improvement in dosimetry accuracy and enabled meaningful hazard rankings among ENMs. The ISDD model was subsequently adapted to utilize the VCM effective density, is now referred to as the VCM-ISDD 54 . The DG model developed by the authors and used in the protocol presented here provides deposition, as well as concentration metrics as a function of time, both at the bottom of the well and as a function of position in the well 37 . As mentioned above, the DG model also allows simultaneous simulation of all particles sizes in the distribution of a polydisperse suspension, and modeling of soluble materials. The DG model also allows modeling of variable binding kinetics ('stickiness') at the bottom of the well, based on a user-defined dissociation constant, K D . As described in detail in our original report of the model, lower boundary binding kinetics can substantially affect delivered dose metrics 37 . Specifically, a perfectly sticky boundary, as used by the ISDD model, can overestimate the rate of particle settling, particularly for relatively small and light particles.
As described in detail in the original report, the integrated methodology presented here, including ENM dispersion preparation, characterization, and dosimetry using the DG model, was validated by comparing predicted concentration profiles along the vertical axis for suspensions of metal oxide ENMs with empirical measurements of ENM concentration in thin cryosections from flash-frozen cylinders of ENM suspensions 37 . In addition, goldstandard 3D computational fluid dynamics (CFD) models were developed and used to validate the DG model and the integrated methodology presented here. Very close agreement was observed between empirical cryosection measurements and both the DG and CFD model predictions. The methodology had been further validated by our lab in terms of predicting biological outcome in an in vitro study of the hazard ranking of a large panel of lowaspect-ratio ENMs 53 . Details on the validation of this integrated in vitro dosimetry methodology can be found in papers previously published by the authors 33, 36, 37, 53 .
Experimental design
Although the multistep protocol described above is suitable for the majority of ENMs, in some circumstances it may be necessary to adapt the protocol to accommodate the specific characteristics of the ENM being used. ENMs that may require modification of the protocol include those that are substantially soluble, those that form particularly large agglomerates, and those that are buoyant.
The dissolution of ENMs over time can have important effects on properties of ENM dispersions and fate, and transport modeling, and must be taken into account for soluble materials (e.g., Ag, ZnO). For metal and metal oxide ENMs, dissolution over time can be determined by using one of several available techniques, including ultracentrifugation, either alone or combined with ultrafiltration 78, 79 , and dialysis [79] [80] [81] , to remove undissolved particles, and subsequently quantifying the dissolved metal concentration in the resulting supernatants, ultrafiltrates, or dialysates by inductively coupled plasma mass spectrometry.
The dissolved concentrations can then be used to determine the dissolved fraction and make the necessary adjustments to characterization and particle kinetics modeling and dose metrics, as described in detail below.
Some ENMs may also form large agglomerates containing very high amounts of medium, such that the total agglomerate volume is large, and it may block or overfill the PCV tube capillary. In these cases, it may be necessary to repeat the protocol using a lower concentration, or to use alternative methods such as AUC to estimate effective density. At the other extreme, ENMs that form small agglomerates may require longer than the 1 h recommended (at 3,000g) in this protocol to become completely pelleted. For example, given a VCM liquid column height of 3 cm, particles with a typical average effective density of 1.5 g/ml and diameter of 200 nm would require ~13 min to become pelleted, and those with a diameter of 100 nm would require 50 min. However, particles with a diameter of 50 nm would require 198 min to become pelleted (~3.3 h). This time would be further increased for ENMs forming agglomerates with lower effective densities (sedimentation velocity is proportional to the difference between medium density and ENM agglomerate effective density). Thus, when working with ENMs that form small and/or low-density agglomerates, the centrifugation time for the VCM method may need to be increased substantially, and in some cases in which particles are smaller than ~50 nm, and/or have relatively low effective densities, it may be more efficient and practical to use AUC to determine effective density.
Buoyant ENMs with density less than that of the medium require adaptation of the VCM method or use of an alternative method (e.g., AUC) for measurement of effective density. Because buoyant ENM agglomerates move toward, rather than away from, the rotor center during centrifugation, it is necessary to perform the VCM with the PCV tubes inverted in the centrifuge. Detailed methods for making these modifications and measuring effective density of buoyant particles are included in a newly published paper by the authors 46 , and will not be presented here.
No specific controls are required for the dispersion preparation and determination of size by DLS, for effective density by the VCM method, or for subsequent dosimetry modeling. However, it is important that DLS instrumentation be regularly maintained, calibrated, and validated according to the manufacturers' guidelines. For example, standard particles of known size are available from manufacturers of DLS instruments, and they should periodically be used to verify that the instrument is correctly measuring hydrodynamic diameters within the tolerance specified by the manufacturer.
Finally, the type of cell culture system and specific cells types used for in vitro testing depend on the exposure type being emulated (e.g., inhalation, dermal exposure, ingestion) and specific types of effects being investigated. For example, common immortal cell lines used for investigating possible effects of inhalation exposure include human small airway epithelial cells, human microvascular endothelial cells, and human THP-1 macrophages 26, 55, 60, 82 . However, it is worth noting that the proposed methodology and protocols are independent of cell type and cellular assays.
Limitations
The proposed standardized methodology is limited to relatively low-aspect-ratio ENMs. Although this includes the vast majority of metal, metal oxide, and many carbon-based ENMs, as well as incidental nanoparticles (e.g. resulting naturally via combustion processes) and particles released across the life cycle of NEPs, this methodology is not suited to high-aspect-ratio carbon nanotubes (CNTs) or other 2D ENMs such as graphene. This is because (i) dispersion of hydrophobic ENMs such as CNTs and graphene in aqueous media might be difficult using the approach described in part 1, as it often requires the use of specially designed surfactants or other novel dispersants 83, 84 ; and (ii) the sedimentation and diffusion equations underlying fate and transport modeling assume that particles or agglomerates can be approximated as spheres with a given hydrodynamic diameter. The hydrodynamic diameter, which is the product of the diameter of the sphere of equivalent volume and a frictional coefficient that accounts for nonspherical shape and surface irregularity, is used to calculate both the sedimentation and diffusion coefficients needed to model transport. Hydrodynamic diameter can be measured directly by methods such as DLS, and it can often be estimated for nonspherical shapes when only the equivalent diameter is known. For prolate or oblate ellipsoids, or rigid rods, for example, it is possible to approximate frictional coefficients in order to arrive at hydrodynamic diameters and enable fate and transport modeling using the DG model. However, for very long rods (nonagglomerated CNTs), or non-rigid or branching structures (e.g., nanofibrillar cellulose), the situation is more complex, and fate and transport modeling approaches have as yet not been worked out. In such cases, it may be possible to use an empirical method, such as flash-freezing columns of suspension at various time points, cryosectioning those frozen columns, and applying various methods to quantify the content of the nanomaterial in each section. Investigations into the internalized particle dose via mass spectrometry 85 , or tracking of cellular uptake of fluorescent-labeled or radiolabeled particles 55 may provide alternative approaches for estimating dosimetry in these cases. Similarly, the ENM suspension preparation protocols described here may not be suitable to generating relatively monodisperse suspensions for such high-aspect-ratio and hydrophobic ENMs. More research is needed to determine suitable methods for preparing and characterizing suspensions and performing dosimetry analysis for such ENMs. • sonicator cup horn to the converter, and the converter to the power supply (i.e., the Branson S-450D). Secure the cup horn within the acoustic enclosure. Connect the cup horn coolant inlet port to a cold-water source, and connect the outlet and overflow ports to a drain using 0.25-inch plastic tubing (for the Branson 3-inch cup horn). Adjust the three-pronged clamp to hold conical centrifuge tubes in the center of the cup horn. proceDure part 1: enM dispersion preparation • tIMInG 2.5-5 h  crItIcal As described in 'Equipment Setup', the sonicator must be calibrated calorimetrically before use to ensure that the exact delivered sonication energy is known and reported for any experiment. This will also ensure that sonicators from different manufacturers or models can be used to deliver the specific sonication energy of interest.
MaterIals

REAGENTS
1| Sonicator calorimetric calibration to obtain DSE rate (DSE/min).
Drill a hole that is large enough for the thermometer probe (a suitable hole can be created with a box cutter) in the cap of a 50-ml conical centrifuge tube.
2| Add 50 ml of deionized water to the 50-ml conical centrifuge tube.
3|
Insert the thermometer probe through the hole and into the water in the tube.
4|
Turn the thermometer on.
5|
Position and secure the tube in a three-pronged clamp in the center of the cup horn.
6|
Turn the sonicator power on, and select and record power settings (for example, 75% amplitude, continuous mode).
7|
Turn on the cup horn water source and adjust flow so that the sample meniscus is aligned with the water level in the cup.
8|
Turn the sonicator power on.
9|
Record the temperature every 10-30 s until the temperature stabilizes (~3-5 min), and then turn the sonicator power off. ? troublesHootInG 10| Repeat Steps 2-9 two times to generate a total of three data sets.
11| Calculate the delivered acoustic power P(W = J/s) as
where dT/dt is the slope of temperature (K) vs. time (s), M is the mass of water (5 g for 5 ml deionized water), and C p is the specific heat of water (4.186 J/g °K).
12| Calculate and record the average power, P(J/s), from the three measurements (for the specific sonicator and sonicator settings used).
13|
Determination of DSE cr . Weigh ~1 mg of nanoparticle powder into a 15-ml conical centrifuge tube.
14|
Add deionized water to achieve a final concentration of 0.5 mg/ml.
15|
Vortex the suspension at high speed for 30 s.
16| Remove 1 ml of the suspension, measure the mean hydrodynamic diameter using DLS or other size characterization instrumentation, and return the sample to the tube.
17|
Adjust the sonicator power settings to those used during calibration (Step 6), and turn the sonicator power on. 19| Calculate DSE (J/ml) for the sonication step as
where P is the delivered acoustic power determined in the calibration steps (Steps 1-12), t is time in seconds, and V is the volume of the suspension in milliliters.
20| Remove 1 ml of the suspension, measure the mean hydrodynamic diameter using DLS or other size characterization instrumentation, and return the sample to the tube.
21|
Repeat Steps 18-20 until the mean hydrodynamic diameter decreases by <5% between steps.
22| Plot cumulative DSE (x axis) vs. mean hydrodynamic diameter (y axis).
23| Identify the DSE cr (J/ml) as the cumulative DSE at which further sonication does not further reduce the mean hydrodynamic diameter by more than 5% (slope approaches zero).
24|
Remove a 100-µl sample of suspension, dilute it to 100 µg/ml in the culture medium of choice, and measure the mean hydrodynamic diameter of the sample by DLS or other size characterization instrumentation.
25|
Repeat size measurement of suspension in culture medium at 24 h.  crItIcal step If the mean size changes substantially (by more than 30%) at 24 h, it may be advisable to repeat Steps 13-25 with additional sonication time until the 24-h postsonication suspension mean size is more consistent with that at time 0. DSE cr refers to the energy per unit volume of suspension required to achieve the smallest possible agglomerates and most stable suspensions over time. Although some change in size over time due to re-agglomeration is not uncommon, large deviations in mean size indicate an unstable suspension, suggesting that additional power is needed to completely disrupt the forces between primary particles.
26| Preparation of suspensions for characterization and use in experiments.
Weigh the amount of nanoparticle powder required for the experiment into a 15-ml conical centrifuge tube.
27|
Add deionized water to achieve a final concentration of 0.5 mg/ml.  crItIcal step Maximum volume for sonication in a typical 3-inch cup horn is ~5 ml. It may not be possible to effectively deliver energy to suspensions of greater volume. If larger amounts of suspension are required, split them into portions of 5 ml each.
28|
29|
Select the sonicator power settings and turn the sonicator power on.  crItIcal step Use the same power settings used to calibrate sonicator and to measure DSE cr .
30| Calculate time t (s) required for sonication as
where V is the volume of suspension (ml) and P is the delivered power (W or J/s) determined by calibration (Steps 1-12 ).
31| Sonicate the suspension for the calculated time required.
32|
Vortex the suspension at high speed for 30 s 33| Dilute to the final desired concentrations in the medium or in the fluid of choice for characterization or experimental studies. 
34| Determination of suspended nanomaterial effective density (ρ EV
. Dilute water suspension prepared as described above in desired medium to make ~4 ml of suspension at 100 µg/ml.
35| Transfer 1 ml of suspension to each of three PCV tubes, and cap the tubes.
36|
Centrifuge the tubes at room temperature (22 °C) for 1 h at 3,000g.
37|
Use the 'easy-read' measuring device to measure the volume of the pellet collected at the bottom of the capillary in each PCV tube. The device resembles a thick ruler. The front face is etched along the top with graduations at 0.025-µl intervals. Insert the PCV tube into the hole on top of the sliding holder so that it rests on the ramp at the back of the ruler. The holder contains a lens to magnify the capillary and ruler graduations. Slide the tube and holder along the ramp until the top edge of the pellet is aligned with the top edge of the ruler. Position your line of sight so that the horizontal crosshair is aligned with the top edge of the ruler, and the vertical line of the crosshair is aligned with the capillary center. If not properly aligned, parallax error will result in measurement error (Fig. 3b) .  crItIcal step It is important to use the easy-read device correctly to avoid errors. ? troublesHootInG 38| Calculate density of the medium, ρ media (g/cm 3 ), by weighing a known volume of medium in a tared vessel, or by subtracting the mass of a preweighed vessel from the mass of the vessel with the medium and dividing by the volume.
39|
Calculate the effective density, ρ EV , for each measured pellet volume using the following equation:
where ρ media is the density of the medium (g/cm 3 ), M ENM is the total mass of nanomaterial (g) in the dispensed volume (1 ml) of suspension (e.g., 1.0 ml × 100 µg/ml × 1 × 10 −6 g/µg = 1.0 × 10 −4 g), and M ENMsol is the mass of dissolved nanomaterial (g) in the dispensed volume (1 ml) of suspension. For insoluble materials, M ENMsol is 0. For soluble materials, M ENMsol must be determined by analyzing the supernatant (e.g., by inductively coupled plasma mass spectrometry) of an ENM suspension after centrifugation. Dissolution measurements are beyond the scope of this paper, but suitable methods can be found in numerous sources in the literature [78] [79] [80] [81] . From the concentration of dissolved ENM, the mass of dissolved ENM can be calculated (e.g., 1.0 ml × 10 µg/ml × 1 × 10 −6 g/µg = 1.0 × 10 −5 g); V pellet is the measured pellet size in centimeters squared (convert measured volume, which is in microliters or millimeters squared, to centimeters squared by dividing by 1,000), and ρ ENM is the density (g/cm 3 ) of the raw nanomaterial (e.g. 5.242 g/cm 3 for Fe 2 O 3 ). SF is the stacking factor, which is the portion of the pellet that is composed of agglomerates (the remaining portion being inter-agglomerate medium). Values for SF may range from 0.634, for random stacking, to the theoretical maximum of 0.74, for ordered stacking 89, 90 . For the roughly spherical agglomerates typically observed with low-aspect-ratio ENMs, we have verified that the theoretical value for random close stacking (0.634) is appropriate, whereas for uniform nonagglomerating spherical ENMs (e.g., gold spheres) the theoretical value for ordered stacking (0.74) should be used 36 .
40|
Calculate the mean ρ EV from the three individual measures.
41| Determination of size (hydrodynamic diameter) distribution.
Power on the Zetasizer Nanoseries 30 min before use.  crItIcal step The following steps describe size characterization using a Zetasizer Nanoseries DLS instrument. For other DLS instruments, refer to the manufacturer's instructions. As discussed in the INTRODUCTION, several other types of instrumentation for measuring colloidal size distribution are available and can be used in place of a DLS instrument. 
45|
Select the material-medium-specific standard operating procedure (SOP, which contains material-and medium-specific properties needed by the instrument) if one exists. If no SOP exists for the specific material and medium, create a new SOP by entering the material-specific refractive index and absorption, and the medium-specific viscosity.
46|
Run the SOP to collect the mean hydrodynamic diameter and the intensity-, number-, and volume-weighted size distributions.  crItIcal step The three types of distributions obtained from DLS (intensity-, number-, and volume-weighted) often differ to a certain extent from one another. Specifically, the intensity-weighted distribution can be relatively skewed toward larger sizes, whereas the number distribution can be skewed toward smaller sizes. For calculation of DSE cr , described above (Steps 13-25), the mean hydrodynamic diameter reported by the instrument is used. For fate and transport modeling, described below, the most accurate results are obtained using the volume-weighted distribution, which best represents the mass distribution of the suspended material. 
48|
Enter the solvent/media properties. Each user input data parameter is listed as uid.name, where 'name' is a descriptive name of the parameter. 'uid.' is a MATLAB data structure, of which all the named parameters are elements. This is followed by the assignment operator '=', a number value, and a closing semicolon; for each parameter, change the associated number value (or values in the case of arrays) to the appropriate datum for your experimental system. A summary of all input parameters is given in table 2. The solvent/media properties to be entered are the solvent viscosity (uid.solvent_viscosity) in Pascal-seconds (Pa s; box 1), the solvent density (uid.solvent_density) in grams per centimeter squared, and the temperature of the system (uid.solvent_temperature) in degrees Celsius.
49|
Enter the particle properties. These include the ENM raw material density (uid.material_density) in grams per centimeter squared, the particle diameters for each particle size species present (uid.particle_diameters) in nanometers, the volume-weighted fraction of the total volume of ENM corresponding to the particle diameters (uid.species_fractions), and the agglomerate or particle effective density (uid.particle_effective_density), in grams per centimeter squared. The particle diameters and corresponding species fractions are arrays, enclosed by square brackets. It is possible to enter a single average particle size, in which case the corresponding species fraction array would contain the single value of 1.0. However, more accurate results can be obtained if the particle size distribution and corresponding fractions (e.g., the volume-weighted size distribution obtained by DLS) are used.
Box 1 | Determination of media dynamic viscosity
Because particle transport rates, both for diffusion and sedimentation, are inversely proportional to media dynamic viscosity, it is important to accurately measure these properties before proceeding to fate and transport modeling. Because viscosity is temperature dependent, it is important that it be measured at the temperature at which the ENM suspensions will be incubated with cells (e.g., 37 °C). For example, at room temperature, the dynamic viscosity of RPMI culture medium supplemented with 10% (vol/vol) heat-inactivated FBS is, by our measurements, 0.00103 Pa s, whereas at 37 °C the viscosity of the same medium is 0.00081 Pa s (22% lower).
A number of options are available for measurement of viscosity, including inexpensive glass U-tube (Ostwald or Cannon-Fenske) viscometers, somewhat more expensive falling-ball viscometers, more expensive rotational viscometers, and others. When selecting a viscometer, be sure that it is capable of measuring in the 0.5-to 2.0-centistokes (cSt) range. The viscosity of water at 22 °C is 1.0 cSt, and most biological fluids and culture media have viscosities between 0.75 and 1.25 cSt.
Methods for proper use of a viscometer are provided by the manufacturers and will not be presented here. Most viscometers yield the kinematic viscosity v, in the centimeter-gram-second unit cSt. Use the following formula to convert to dynamic viscosity, η, in SI units (Pa s), which is the value required for fate and transport modeling inputs (used within the code for calculation of diffusion and sedimentation coefficients):
50|
Enter the experimental parameters. These include the height of the liquid column within the cell culture well (uid.column_height) in millimeters (e.g., 3.0 mm for a typical 96-well plate with 100 µl of suspension per well), the initial concentration of ENM (uid.initial_concentration) in milligrams per centimeter squared, and the total simulation time (uid.simulation_time) in hours. The simulation time should be set to the duration of the in vitro exposure incubation.
51| Enter model parameters. These define the resolution in space and time, of the simulation, and usually do not need to be changed from their default values. The model divides the height of the well into a number of small compartments, and performs alternating short rounds of sedimentation and diffusion between these compartments. The compartment height (uid.compartment_height) specifies the height of these small compartments in millimeters. It is usually set to 0.005, and it should not require changing, unless a finer resolution of the vertical concentration profile is desired. The duration of the short rounds of sedimentation and diffusion is specified by the simulation time interval (uid.simulation_time_interval), in seconds. The default is 0.5 s. Larger values (1.0-2.0 s) may reduce the time for the simulation to run; however, this will also reduce the accuracy of the results.
52|
Enter output data parameters. These specify the temporal and spatial resolutions of the dosimetry output data, and options that may save time if only some of the output is required. The output time interval (uid.output_time_interval), in
Box 2 | Analysis of DG model output data
The Excel output file generated by the DG model contains several relevant dose metrics at each output time point (defined by the chosen parameters uid.simulation_time and uid.output_time_interval) during the simulated time. These metrics are summarized in table 2, and include mass, particle number, and surface area concentrations per unit of volume, as well as per unit of well-bottom area, and fraction of administered ENM deposited (within the bottom compartment). For materials that are soluble, the concentration of dissolved material is also provided, and mass concentrations are provided both including and excluding the dissolved-material contribution. In addition, if the simulation includes adsorption (uid.sticky is set to 1), the mass bound per unit of area and the percentage of the bottom occupied by adsorbed particles are provided. The output Excel file contains multiple sheets. In the sheet named 'Bot Summary', the dose metrics in table 2 are given for each time point at the bottom of the well (i.e., within the bottom compartment, representing the cell microenvironment, the height of which is defined by the value of the parameter uid.output_compartment_height selected for the simulation-typically 0.01 mm or 10 µm). In addition to the Bot Summary sheet, the DG output file contains one sheet for each of the above parameters, in which the value of the parameter over time is given at the center z position of each compartment (defined by the uid.output_compartment_height value selected when running the simulation). minutes, specifies the time between saved data points. The output compartment height (uid.output_compartment_height), in millimeters, is the vertical resolution of the output concentration profile. It is also the height of the bottom compartment, which defines the thickness of the cell microenvironment. Deposition metrics are calculated based on the amount of material in this compartment.
53| Enter dissolution parameters. If the ENM being analyzed is soluble, and dissolution data have been obtained, they can be entered here. The initial dissolution fraction (uid.initial_dissolution) is the fraction of ENM dissolved at the start of the incubation. The dissolution rate type (uid.dissolution_rate_type) defines the type of dissolution data that will be provided. If no further dilution occurs after the initial dissolution, then the dissolution rate type should be set to 0. If dissolution occurs at a constant rate (a constant fraction of ENM dissolves per unit of time) then the dissolution rate type should be set to 1. If dissolution is not linear, and measurements were made at multiple time points, then the dissolution rate type should be set to 2. The dissolution rate (uid.dissolution_rate) is relevant only when the dissolution rate type is set to 1, and specifies the fraction of the total ENM that dissolves per hour. The last two dissolution parameters, dissolution times (uid.dissolution_times) and dissolution fractions (uid.dissolution_fractions), are relevant if the dissolution rate type is set to 2, and specify the time points and dissolved fractions in the dissolution curve.
54| Enter particle-cell adsorption parameters. These parameters are used to control whether and with what affinity particles are adsorbed to the cell surfaces at the bottom of the well. The uid.sticky parameter determines whether adsorption occurs (set to 1) or not (set to 0). If this parameter is set to 0, then the value of the second adsorption parameter, the dissociation constant (uid.adsorption_dissociation_constant), in units of molarity, is ignored and irrelevant, and the bottom boundary condition for the simulation is perfectly reflective. If uid.sticky is set to 1, then the degree of stickiness is determined by the dissociation constant. Typically, sizable effects on transport (dose metrics) occur only for dissociation constant values less than ~1 × 10 −9 M.
55|
Save changes and execute the .m file. While the simulation is running, the percentage completed will be displayed in the MATLAB command window.
56|
Export the results to an Excel file. When the simulation is complete, a prompt will appear for providing a name and location for the output Excel file. This file contains dose metrics over the course of the simulation time. See box 2 for a description of the file format.
? troublesHootInG Troubleshooting advice can be found in table 3. 
antIcIpateD results
The step-by-step protocol detailed above can be used to determine in vitro dose metrics for most low-aspect-ratio ENMs, including incidental nanoparticles (e.g., resulting naturally via combustion processes) and nano-sized particles released across the life cycle of NEPs.
To illustrate the use of this protocol with a typical ENM, we provide here highlights for a case study using a common metal oxide ENM (Fe 2 O 3 ) to determine dose metrics in a 96-well plate over 24 h. The Fe 2 O 3 material for this case study was made by flame spray pyrolysis using the Harvard VENGES 86 , as described previously 42, 86, 87 . The powder characterization and colloidal characterization in DMEM + 10% (vol/vol) FBS for this material are presented in table 4. The sonicator used was a Branson model S-450D with 3-inch inside-diameter cup horn, which was calibrated using Steps 1-12 and determined to deliver a power of 2.59 J/s.
Determination of critical delivered sonication energy (Dse cr )
The DSE cr value for the Fe 2 O 3 material was determined following Steps 13-25. Mean hydrodynamic diameter (obtained by DLS) is shown plotted as a function of applied energy in Figure 4 . From this graph, we determined that the DSE cr value for the material is 345 J/ml. The mean hydrodynamic diameter in medium immediately after dilution was determined by DLS to be 976 nm. At 24 h after dispersion in medium, the mean hydrodynamic diameter was found by DLS to be 717 nm, suggesting that the formed agglomerates were not perfectly stable. As the difference was within 30%, it was deemed acceptable. It is possible that in some cases sonication in water for a longer time (selecting a higher DSE cr value) will further improve stability of the suspension in medium. For this material, sonication at a higher DSE value did not improve the stability of the media suspension (data not shown). The effective density (ρ EV ) for the Fe 2 O 3 ENM in DMEM + 10% (vol/vol) FBS was measured using the VCM according to . The density of the medium, total and dissolved mass of ENM, raw ENM density, and SF used in the calculation of effective density were as follows: ρ media = 1.0084 g/cm 3 . M ENM = 1.0 ml × 100 µg/ml × 1 × 10 −6 g/µg = 1.0 × 10 −4 g. M ENMsol = 0.0 g (insoluble material). ρ ENM = 5.242 g/cm 3 (Fe 2 O 3 ). SF = 0.634. The three measured pellet volumes and calculated effective densities are shown in table 5. The mean effective density from these three measurements was 1.483 g/cm 3 .
The size distribution of the suspension was measured by DLS (Steps 41-46) and is represented in Figure 5 .
analysis of particle kinetics and calculation of dose metrics with fate and transport modeling
The effective density-and volume-weighted size distribution determined above were used to determine dose using the DG model. In the MATLAB file 'DG_nanotransport_simulator.m' (supplementary software), the list of sizes and corresponding volume-weighted fractions (from DLS), and effective density have been assigned to the relevant variables, and all other variables have been set as described above in Steps 48-54. The simulation was then run, and data were exported to the file 'DG_output_Fe2O3_CaseStudy.xlsx' (supplementary Data). The output metrics described above in box 2 and table 2 can be found in this file. As described in box 2, all metrics at the bottom of the well are presented in the 'Bot Summary' tab, and there are additional tabs for each metric that provide each metric as a function of both time and vertical position in the well. The mean for each metric has been calculated and added to the Bot Summary tab. The fraction deposited and mass concentration vs. time plots automatically generated by the program are shown in Figure 6 . From these plots, it is clear that the agglomerates sediment relatively quickly to reach a maximum equilibrium concentration at the bottom of the well (24.8 mg/ml) and fraction deposited (0.82) at ~11 h. The mean concentration at the bottom of the well (22.7 mg/ml) and mean fraction deposited (0.76) over the simulated exposure time are also presented in the output graphs in Figure 6 . 
